Slide Decks

This slide deck provides an overview of the current knowledge on the epidemiology, pathology, and clinical management of post-stroke cognitive impairment and dementia.

This slide deck explores the epidemiology and burden of stroke and includes illustrations of the many different neurobehavioral consequences related to the burden of stroke.

In this slide deck, you will find current knowledge about delirium in relation to stroke through case presentations, facts, and illustrations covering topics such as risk factors for post-stroke delirium and the occurrence of delirium in acute stroke.

Dementia is an umbrella term used to describe a state where an individual has lost the ability to carry out daily life activities independently because of cognitive impairment that is not due to an underlying psychiatric condition. Alzheimer’s disease (AD) refers to the abnormal presence of Aβ and tau proteins, which define AD among many other neurodegenerative diseases. Dementia -including dementia due to AD- is likely to be underestimated because of underdiagnosis and misdiagnosis.

This slide deck summarizes the current knowledge surrounding the use of psychedelics for the treatment of depression. Specifically, our focus centers on serotonergic psychedelics, commonly referred to as classical psychedelics. These psychedelics primarily function as agonists or partial agonists at the serotonin 2A receptor (5-HT2A receptor).

In this slide deck you will find basic concepts and definitions related to approaches such as disease-stage-specific treatment and psychosocial therapies. The slide deck also offers a brief introduction to general considerations for managing Alzheimer’s disease.